Nature Search

Individual electrons detected after the interaction of ionizing radiation with gases

O. H. W. Siegmund
J. L. Culhane
P. W. Sanford
Research25 Feb 1982
Nature

Volume: 295, P: 678-679
Determination of the spin and parity of all-charm tetraquarks

The CMS Collaboration reports the measurement of the spin, parity, and charge conjugation properties of all-charm tetraquarks, exotic fleeting particles formed in proton–proton collisions at the Large Hadron Collider.

A. Hayrapetyan
V. Makarenko
A. Snigirev
ResearchOpen Access03 Dec 2025
Nature

Volume: 648, P: 58-63
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils

Tatsuhiko Kodama
Mason Freeman
Monty Krieger
Research08 Feb 1990
Nature

Volume: 343, P: 531-535
Designing better solar cookers

DANIEL M. KAMMEN
WILLIAM F. LANKFORD
Research02 May 1991
Nature

Volume: 351, P: 21
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Evelyn A. Kurt-Jones
Lana Popova
Robert W. Finberg
Research01 Nov 2000
Nature Immunology

Volume: 1, P: 398-401
Growth of Pulmonary Alveolar Macrophages in vitro

S. C. SODERLAND
Y. NAUM
Research21 Sept 1973
Nature

Volume: 245, P: 150-152
Elliptic anisotropy measurement of the f₀(980) hadron in proton-lead collisions and evidence for its quark-antiquark composition

The quark structure of the f₀(980) hadron is still unknown after 50 years of its discovery. Here, the CMS Collaboration reports a measurement of the elliptic flow of the f₀(980) state in proton-lead collisions at a nucleon-nucleon centre-of-mass energy of 8.16 TeV, providing strong evidence that the state is an ordinary meson.

A. Hayrapetyan
A. Tumasyan
A. Zhokin
ResearchOpen Access27 Aug 2025
Nature Communications

Volume: 16, P: 1-19
Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II

Lucia Rohrer
Mason Freeman
Monty Krieger
Research08 Feb 1990
Nature

Volume: 343, P: 570-572
IUE observations of the hot components in two symbiotic stars

A. G. Michalitsianos
M. Kafatos
S. P. Maran
Research13 Mar 1980
Nature

Volume: 284, P: 148-150
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

Christian P. Larsen
Eric T. Elwood
Thomas C. Pearson
Research30 May 1996
Nature

Volume: 381, P: 434-438
Inhibition of Fatal Anaphylaxis in Mice inoculated with a Virus-induced Leukaemic Tumour Extract

P. G. STANSLY
P. E. ScHIOP
R. L. COMBS
Research08 Jul 1967
Nature

Volume: 215, P: 191-192
Measurement of the Higgs boson width and evidence of its off-shell contributions to ZZ production

The CMS Collaboration reports evidence for off-shell Higgs boson contributions in the production of Z boson pairs, and measures the width of the Higgs boson, which is inversely related to its lifetime.

A. Tumasyan
W. Adam
W. Vetens
ResearchOpen Access20 Oct 2022
Nature Physics

Volume: 18, P: 1329-1334
A portrait of the Higgs boson by the CMS experiment ten years after the discovery

The most up-to-date combination of results on the properties of the Higgs boson is reported, which indicate that its properties are consistent with the standard model predictions, within the precision achieved to date.

A. Tumasyan
W. Adam
A. Zhokin
ResearchOpen Access04 Jul 2022
Nature

Volume: 607, P: 60-68
Observation of triple J/ψ meson production in proton-proton collisions

The CMS Collaboration reports the study of three simultaneous hard interactions between quarks and gluons in proton–proton collisions. This manifests through the concurrent production of three J/ψ mesons, which consist of a charm-quark–antiquark pair.

A. Tumasyan
W. Adam
W. Vetens
ResearchOpen Access19 Jan 2023
Nature Physics

Volume: 19, P: 338-350
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Sera from vaccinated individuals and some monoclonal antibodies show a modest reduction in neutralizing activity against the B.1.1.7 variant of SARS-CoV-2; but the E484K substitution leads to a considerable loss of neutralizing activity.

Dami A. Collier
Anna De Marco
Ravindra K. Gupta
Research11 Mar 2021
Nature

Volume: 593, P: 136-141
SARS-CoV-2 evolution during treatment of chronic infection

Chronic infection with SARS-CoV-2 leads to the emergence of viral variants that show reduced susceptibility to neutralizing antibodies in an immunosuppressed individual treated with convalescent plasma.

Steven A. Kemp
Dami A. Collier
Ravindra K. Gupta
Research05 Feb 2021
Nature

Volume: 592, P: 277-282
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

In this study, Aggarwal and colleagues perform prospective sequencing of SARS-CoV-2 isolates derived from asymptomatic student screening and symptomatic testing of students and staff at the University of Cambridge. They identify important factors that contributed to within university transmission and onward spread into the wider community.

Dinesh Aggarwal
Ben Warne
Ian G. Goodfellow
ResearchOpen Access08 Feb 2022
Nature Communications

Volume: 13, P: 1-16
Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network

Mammalian genomes are scattered with repetitive sequences, but their biology remains largely elusive. Here, the authors show that transcription can initiate from short tandem repetitive sequences, and that genetic variants linked to human diseases are preferentially found at repeats with high transcription initiation level.

Mathys Grapotte
Manu Saraswat
Charles-Henri Lecellier
ResearchOpen Access02 Jun 2021
Nature Communications

Volume: 12, P: 1-18
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Harry Björkbacka
Vidya V Kunjathoor
Mason W Freeman
Research14 Mar 2004
Nature Medicine

Volume: 10, P: 416-421
The role of PPAR-γ in macrophage differentiation and cholesterol uptake

Kathryn J. Moore
Evan D. Rosen
Mason W. Freeman
Research01 Jan 2001
Nature Medicine

Volume: 7, P: 41-47
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Genetic and testing data from England show that the SARS-CoV-2 variant of concern B.1.1.7 has a transmission advantage over other lineages.

Erik Volz
Swapnil Mishra
Neil M. Ferguson
Research25 Mar 2021
Nature

Volume: 593, P: 266-269
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission

Post-international travel quarantine has been widely implemented to mitigate SARS-CoV-2 transmission, but the impacts of such policies are unclear. Here, the authors used linked genomic and contact tracing data to assess the impacts of a 14-day quarantine on return to England in summer 2020.

Dinesh Aggarwal
Andrew J. Page
Ewan M. Harrison
ResearchOpen Access23 Feb 2022
Nature Communications

Volume: 13, P: 1-13
A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia

Coronaviruses may spill over from bats to humans. This study uses epidemiological data, species distribution models, and probabilistic risk assessment to map overlap among people and SARSr-CoV bat hosts and estimate how many people are infected with bat-origin SARSr-CoVs in Southeast Asia annually.

Cecilia A. Sánchez
Hongying Li
Peter Daszak
ResearchOpen Access09 Aug 2022
Nature Communications

Volume: 13, P: 1-12
A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies

Winston Patrick Kuo
Fang Liu
Tor-Kristian Jenssen
Research02 Jul 2006
Nature Biotechnology

Volume: 24, P: 832-840
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Primary biliary cirrhosis is an autoimmune liver disease with poor therapeutic options. Here Cordell et al. a perform meta-analysis of European genome-wide association studies identifying six novel risk loci and a number of potential therapeutic pathways.

Heather J. Cordell
Younghun Han
Katherine A. Siminovitch
ResearchOpen Access22 Sept 2015
Nature Communications

Volume: 6, P: 1-11
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing

Recommendations are given on optimal read coverage and selection of calling algorithm to maximize the reproducibility of cancer mutation detection in whole-genome or whole-exome sequencing.

Wenming Xiao
Luyao Ren
Leming Shi
Research09 Sept 2021
Nature Biotechnology

Volume: 39, P: 1141-1150
A communal catalogue reveals Earth’s multiscale microbial diversity

As phase 1 of the Earth Microbiome Project, analysis of 16S ribosomal RNA sequences from more than 27,000 environmental samples delivers a global picture of the basic structure and drivers of microbial distribution.

Luke R. Thompson
Jon G. Sanders
Hongxia Zhao
ResearchOpen Access01 Nov 2017
Nature

Volume: 551, P: 457-463
Ongoing harlequin toad declines suggest the amphibian extinction crisis is still an emergency

The status of the harlequin toads has not improved since 2004 despite species rediscoveries accompanied by increasing conservation efforts, and habitat destruction and degradation continue to threaten them today, according to an analysis of population status records over the period 2004–2022.

Stefan Lötters
Amadeus Plewnia
Enrique La Marca
ResearchOpen Access11 Nov 2023
Communications Earth & Environment

Volume: 4, P: 1-8
eLiXiRs for restraining inflammation

New data implicate the LXRs, a class of nuclear hormone receptors, in reducing inflammation. When activated, these receptors ease inflammation in three mouse models. The results are relevant to atherosclerosis, Alzheimer disease, sepsis and other inflammatory disorders (pages 213–219).

Mason W. Freeman
Kathryn J. Moore
News & Views01 Feb 2003
Nature Medicine

Volume: 9, P: 168-169
Observation of the rare B_s⁰ →µ⁺µ⁻ decay from the combined analysis of CMS and LHCb data

Combined analysis of proton-proton collision data from the Large Hadron Collider at CERN by the CMS and LHCb collaborations leads to the observation of the extremely rare decay of the strange B meson into muons; the result is compatible with the standard model of particle physics, and does not show any signs of new physics, such as supersymmetry.

V. Khachatryan
A.M. Sirunyan
E. Pesen
ResearchOpen Access13 May 2015
Nature

Volume: 522, P: 68-72
US immigration order strikes against biotech

Jeremy M Levin
Steven H Holtzman
Sandford (Sandy) Zweifach
Correspondence07 Mar 2017
Nature Biotechnology

Volume: 35, P: 204-206
Correction: Corrigendum: A network-based analysis of systemic inflammation in humans

Steve E. Calvano
Wenzhong Xiao
Michael A. West
Amendments and Corrections01 Dec 2005
Nature

Volume: 438, P: 696
NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges

Commercializing innovations in academic environments is notoriously challenging. Here, we describe the progress of the NIH Centers for Accelerated Innovations program — initiated in 2013 to address these challenges — which we believe could help set a new standard for the early-stage commercialization of biomedical innovations in academic environments.

Elliott M. Antman
Paul E. Di Corleto
Lesley Watts
Comments & Opinion04 Aug 2017
Nature Reviews Drug Discovery

Volume: 16, P: 663-664
Author Correction: A portrait of the Higgs boson by the CMS experiment ten years after the discovery

A. Tumasyan
W. Adam
A. Zhokin
Amendments and CorrectionsOpen Access18 Oct 2023
Nature

Volume: 623, P: E4
Publisher Correction: Observation of triple J/ψ meson production in proton-proton collisions

A. Tumasyan
W. Adam
W. Vetens
Amendments and CorrectionsOpen Access12 Dec 2023
Nature Physics

Volume: 20, P: 332
Publisher Correction: Observation of triple J/ψ meson production in proton-proton collisions

A. Tumasyan
W. Adam
W. Vetens
Amendments and CorrectionsOpen Access27 Feb 2023
Nature Physics

Volume: 19, P: 461
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier
Anna De Marco
Ravindra K. Gupta
Amendments and Corrections21 Jul 2022
Nature

Volume: 608, P: E24
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp
Dami A. Collier
Ravindra K. Gupta
Amendments and Corrections21 Jul 2022
Nature

Volume: 608, P: E23
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

The International Multiple Sclerosis Genetics Consortium reports the discovery of 48 new susceptibility variants for multiple sclerosis through targeted follow-up of immune-related loci. They also report fine mapping of association signals at established susceptibility loci and provide insights into the immune system processes underlying this disease.

Ashley H Beecham
Nikolaos A Patsopoulos
Jacob L McCauley
Research29 Sept 2013
Nature Genetics

Volume: 45, P: 1353-1360
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer
Garrett Hellenthal
Alastair Compston
Research10 Aug 2011
Nature

Volume: 476, P: 214-219
Author Correction: Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network

Mathys Grapotte
Manu Saraswat
Charles-Henri Lecellier
Amendments and CorrectionsOpen Access01 Mar 2022
Nature Communications

Volume: 13, P: 1
Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux

Rafique M. Islam
Mohsen Pourmousa
Alan T. Remaley
ResearchOpen Access13 Feb 2018
Scientific Reports

Volume: 8, P: 1-15
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

NAFLD is growing in prevalence worldwide, and has emerged as a leading cause of end-stage liver disease in many countries. In this Review, the authors describe the global epidemiology of NAFLD, discuss associated risk factors and outline challenges for screening and management.

Zobair Younossi
Quentin M. Anstee
Elisabetta Bugianesi
Reviews20 Sept 2017
Nature Reviews Gastroenterology & Hepatology

Volume: 15, P: 11-20
Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers

This multiple ascending dose study of the selective aldosterone synthase inhibitor baxdrostat demonstrated a dose-dependent reduction in plasma aldosterone with no meaningful effect on plasma cortisol. There were no deaths or serious adverse events, and all treatment-emergent adverse events in subjects receiving baxdrostat were mild in severity.

Mason W. Freeman
Mary Bond
Jonathan Isaacsohn
ResearchOpen Access20 Oct 2022
Hypertension Research

Volume: 46, P: 108-118
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer

Sian M. Noble
Kirsty Garfield
Jenny L. Donovan
ResearchOpen Access16 Jul 2020
British Journal of Cancer

Volume: 123, P: 1063-1070
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis

Debra Van Egeren
Khushi Kohli
Zenta Walther
ResearchOpen Access09 Nov 2022
Scientific Reports

Volume: 12, P: 1-6
Germline BCL-2 sequence variants and inherited predisposition to prostate cancer

L R Kidd
A Coulibaly
R A Kittles
Research30 May 2006
Prostate Cancer and Prostatic Diseases

Volume: 9, P: 284-292

Search

Filter By:

Search

Quick links